Acura Pharmaceuticals
Manufacturing · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
616 N North Ct Ste 120, Palatine, Illino...Phone Number
(847) 705-7709Website
www.acurapharm.comRevenue
<$5 MillionStock Symbol
ACURIndustry
About Acura Pharmaceuticals
Acura Pharmaceuticals Org Chart
Vice President, Technical Affairs
Is Acura Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Acura Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Acura Pharmaceuticals
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Acura Pharmaceuticals has new funding data
Check if Acura Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Acura Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Acura Pharmaceuticals recently announced quarterly report
Acura Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Acura Pharmaceuticals launches new products
Recommended Actions
Find VP level buyers at Acura Pharmaceuticals
Find more new buyers
Compare Similar Companies to Acura Pharmaceuticals
Compare insights from companies similar to Acura Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Acura Pharmaceuticals
Company Profile Activity
Activity Insights
Acura Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Acura Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Acura Pharmaceuticals.
Acura Pharmaceuticals financials insights
Gather financial insights about Acura Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$534K
Debt
$600K
Debt
$10M
Stock Offering
$5M
Debt
$150K
Debt
$266K
Acura Pharmaceuticals Tech Stack
A closer look at the technologies used by Acura Pharmaceuticals
Most Recent Scoops
Acura Pharmaceuticals News & Media
Debt-laden Acura Pharmaceuticals (ACUR) flags May 2026 financing and bankruptcy risk
Acura Pharmaceuticals adds AD Pharma loans, lifting secured debt to $10.3M, and warns it may scale back or terminate operations and seek bankruptcy without new financing by end of May 2026.Acura Pharmaceuticals secures additional financing By Investing.com
Acura Pharmaceuticals secures additional financingAcura Pharmaceuticals secures additional financing By Investing.com
Acura Pharmaceuticals secures additional financingAcura Pharmaceuticals Provides Development Update on LTX-03
PALATINE, Ill., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that the LTX-03 (hydrocodone bitartrate and acetaminophen) tablets using Acura’s LIMITx technology manufactured in the three New Drug Application (“NDA”) required registration batches successfully passed testing at the six month time point in an ongoing shelf life study when stored at normal temperature and humidity conditions, also known as controlled room temperature (“CRT”). The patente
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Acura Pharmaceuticals
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine a... Read More